Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE4.1900
- TODAY'S CHANGE (%)0.2000 (5.0125%)
- Bid / Lots4.0100/ 1
- Ask / Lots4.5000/ 5
- Open / Previous Close4.0000 / 3.9900
- Day Range
- 52 Week Range
- Volume1,494,830
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 6501 | 4 |
| 09:34 ET | 3310 | 4.005 |
| 09:36 ET | 800 | 4.005 |
| 09:38 ET | 6100 | 4.07 |
| 09:39 ET | 2150 | 4.1025 |
| 09:41 ET | 1608 | 4.08 |
| 09:43 ET | 1500 | 4.075 |
| 09:45 ET | 3920 | 4.045 |
| 09:48 ET | 1765 | 4.05 |
| 09:50 ET | 1800 | 4.04 |
| 09:52 ET | 620 | 4.045 |
| 09:54 ET | 420 | 4.04 |
| 09:56 ET | 100 | 4.03 |
| 09:57 ET | 300 | 4.02 |
| 09:59 ET | 500 | 4.03 |
| 10:01 ET | 100 | 4.02 |
| 10:03 ET | 3800 | 4.03 |
| 10:06 ET | 200 | 4.025 |
| 10:10 ET | 100 | 4.025 |
| 10:12 ET | 12535 | 4.015 |
| 10:14 ET | 7328 | 4 |
| 10:15 ET | 3900 | 3.995 |
| 10:17 ET | 1400 | 4.005 |
| 10:19 ET | 100 | 4.005 |
| 10:21 ET | 200 | 4.005 |
| 10:24 ET | 3698 | 4.005 |
| 10:26 ET | 2233 | 3.995 |
| 10:28 ET | 326 | 3.995 |
| 10:30 ET | 1746 | 3.995 |
| 10:32 ET | 52302 | 4.03 |
| 10:33 ET | 300 | 4.03 |
| 10:35 ET | 1910 | 4.025 |
| 10:37 ET | 2300 | 4.02 |
| 10:39 ET | 6444 | 4.025 |
| 10:42 ET | 1600 | 4.026 |
| 10:44 ET | 4563 | 4.015 |
| 10:46 ET | 600 | 4.01 |
| 10:48 ET | 1400 | 4.005 |
| 10:50 ET | 940 | 4.005 |
| 10:51 ET | 200 | 4.005 |
| 10:53 ET | 2438 | 4.005 |
| 10:55 ET | 500 | 4 |
| 10:57 ET | 900 | 4 |
| 11:00 ET | 716 | 4.005 |
| 11:02 ET | 852 | 4 |
| 11:04 ET | 8722 | 4 |
| 11:06 ET | 800 | 4.005 |
| 11:08 ET | 200 | 4 |
| 11:09 ET | 1842 | 3.995 |
| 11:11 ET | 656 | 3.995 |
| 11:13 ET | 100 | 3.995 |
| 11:15 ET | 576 | 3.995 |
| 11:18 ET | 11749 | 4.015 |
| 11:20 ET | 12292 | 4.045 |
| 11:22 ET | 6614 | 4.03 |
| 11:24 ET | 1100 | 4.03 |
| 11:26 ET | 738 | 4.035 |
| 11:27 ET | 11258 | 4.035 |
| 11:29 ET | 2206 | 4.02 |
| 11:31 ET | 12737 | 4.065 |
| 11:33 ET | 5895 | 4.08 |
| 11:36 ET | 4879 | 4.075 |
| 11:38 ET | 13702 | 4.055 |
| 11:40 ET | 1038 | 4.06 |
| 11:42 ET | 2100 | 4.03 |
| 11:44 ET | 8807 | 4.025 |
| 11:45 ET | 100 | 4.02 |
| 11:47 ET | 500 | 4.02 |
| 11:49 ET | 1738 | 4.02 |
| 11:51 ET | 700 | 4.02 |
| 11:54 ET | 1093 | 4.025 |
| 11:56 ET | 3200 | 4.02 |
| 11:58 ET | 476 | 4.025 |
| 12:00 ET | 1138 | 4.025 |
| 12:02 ET | 1276 | 4.015 |
| 12:03 ET | 109 | 4.015 |
| 12:05 ET | 2038 | 4 |
| 12:07 ET | 2899 | 4 |
| 12:09 ET | 300 | 4 |
| 12:12 ET | 900 | 4 |
| 12:14 ET | 2885 | 4.005 |
| 12:16 ET | 1200 | 4 |
| 12:18 ET | 200 | 4.005 |
| 12:20 ET | 1173 | 4 |
| 12:21 ET | 300 | 4 |
| 12:23 ET | 1037 | 4.005 |
| 12:25 ET | 1000 | 4 |
| 12:27 ET | 473 | 4.005 |
| 12:30 ET | 100 | 4 |
| 12:32 ET | 100 | 4.005 |
| 12:34 ET | 500 | 4.01 |
| 12:36 ET | 100 | 4 |
| 12:38 ET | 12734 | 4.045 |
| 12:39 ET | 400 | 4.05 |
| 12:41 ET | 706 | 4.05 |
| 12:43 ET | 5512 | 4.06 |
| 12:45 ET | 4699 | 4.05 |
| 12:48 ET | 63464 | 4.03 |
| 12:50 ET | 40790 | 4.07 |
| 12:52 ET | 2400 | 4.08 |
| 12:54 ET | 4858 | 4.07 |
| 12:56 ET | 1987 | 4.055 |
| 12:59 ET | 1000 | 4.065 |
| 01:01 ET | 100 | 4.06 |
| 01:03 ET | 4292 | 4.09 |
| 01:06 ET | 1722 | 4.095 |
| 01:08 ET | 1636 | 4.09 |
| 01:10 ET | 5548 | 4.085 |
| 01:12 ET | 2003 | 4.085 |
| 01:14 ET | 24218 | 4.11 |
| 01:15 ET | 2800 | 4.12 |
| 01:17 ET | 5003 | 4.11 |
| 01:21 ET | 9772 | 4.12 |
| 01:24 ET | 61708 | 4.125 |
| 01:26 ET | 2500 | 4.14 |
| 01:28 ET | 841 | 4.15 |
| 01:30 ET | 2630 | 4.16 |
| 01:32 ET | 3250 | 4.17 |
| 01:33 ET | 13726 | 4.16 |
| 01:35 ET | 1737 | 4.165 |
| 01:37 ET | 15290 | 4.145 |
| 01:39 ET | 6106 | 4.1563 |
| 01:42 ET | 600 | 4.155 |
| 01:44 ET | 2452 | 4.155 |
| 01:46 ET | 1278 | 4.155 |
| 01:48 ET | 5403 | 4.145 |
| 01:50 ET | 6769 | 4.145 |
| 01:51 ET | 6682 | 4.155 |
| 01:53 ET | 1299 | 4.14 |
| 01:55 ET | 1225 | 4.1452 |
| 01:57 ET | 7536 | 4.1201 |
| 02:00 ET | 300 | 4.125 |
| 02:02 ET | 1550 | 4.115 |
| 02:04 ET | 850 | 4.12 |
| 02:06 ET | 1569 | 4.115 |
| 02:08 ET | 984 | 4.115 |
| 02:09 ET | 667 | 4.115 |
| 02:11 ET | 7437 | 4.125 |
| 02:15 ET | 1900 | 4.125 |
| 02:18 ET | 1242 | 4.13 |
| 02:20 ET | 1142 | 4.125 |
| 02:22 ET | 3126 | 4.125 |
| 02:24 ET | 1742 | 4.135 |
| 02:26 ET | 678 | 4.135 |
| 02:27 ET | 2399 | 4.125 |
| 02:29 ET | 784 | 4.125 |
| 02:31 ET | 3201 | 4.115 |
| 02:33 ET | 1478 | 4.12 |
| 02:38 ET | 742 | 4.115 |
| 02:40 ET | 3177 | 4.1 |
| 02:42 ET | 3588 | 4.1 |
| 02:44 ET | 2200 | 4.11 |
| 02:45 ET | 80562 | 4.1 |
| 02:49 ET | 774 | 4.095 |
| 02:51 ET | 4068 | 4.075 |
| 02:54 ET | 1695 | 4.065 |
| 02:56 ET | 300 | 4.06 |
| 02:58 ET | 6701 | 4.075 |
| 03:00 ET | 500 | 4.08 |
| 03:02 ET | 1200 | 4.08 |
| 03:03 ET | 9709 | 4.095 |
| 03:05 ET | 4126 | 4.095 |
| 03:07 ET | 3791 | 4.105 |
| 03:09 ET | 7150 | 4.1063 |
| 03:12 ET | 3715 | 4.095 |
| 03:14 ET | 1842 | 4.095 |
| 03:16 ET | 400 | 4.095 |
| 03:18 ET | 3741 | 4.085 |
| 03:20 ET | 1768 | 4.085 |
| 03:21 ET | 5487 | 4.1 |
| 03:23 ET | 600 | 4.1 |
| 03:25 ET | 292 | 4.1 |
| 03:27 ET | 7167 | 4.1 |
| 03:30 ET | 1203 | 4.09 |
| 03:32 ET | 11534 | 4.085 |
| 03:34 ET | 8351 | 4.095 |
| 03:36 ET | 1000 | 4.1 |
| 03:38 ET | 8358 | 4.1 |
| 03:39 ET | 4068 | 4.1 |
| 03:41 ET | 2994 | 4.095 |
| 03:43 ET | 6548 | 4.095 |
| 03:45 ET | 20388 | 4.135 |
| 03:48 ET | 12120 | 4.115 |
| 03:50 ET | 6968 | 4.129 |
| 03:52 ET | 18937 | 4.135 |
| 03:54 ET | 8217 | 4.145 |
| 03:56 ET | 13438 | 4.135 |
| 03:57 ET | 128321 | 4.2 |
| 03:59 ET | 44432 | 4.19 |
May 31, 2024
May 17, 2024
DJ Autolus Therapeutics Price Target Maintained With a $9.00/Share by Needham, from 1:52PM ET on Friday May 17, 2024 by Dow Jones
1:52PM ET on Friday May 17, 2024 by Dow Jones*DJ Autolus Therapeutics 1Q Loss/Shr 24c >AUTL, from 7:00AM ET on Friday May 17, 2024 by Dow Jones
7:00AM ET on Friday May 17, 2024 by Dow JonesAutolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates, from 7:00AM ET on Friday May 17, 2024 by Dow Jones
7:00AM ET on Friday May 17, 2024 by Dow Jones
May 14, 2024
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress, from 10:00AM ET on Tuesday May 14, 2024 by Dow Jones
10:00AM ET on Tuesday May 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.1B | -3.5x | --- |
Pharvaris NV | 1.0B | -7.4x | --- |
Day One Biopharmaceuticals Inc | 1.2B | -5.3x | --- |
Enliven Therapeutics Inc | 1.1B | -11.7x | --- |
Cassava Sciences Inc | 1.1B | -18.8x | --- |
Verona Pharma PLC | 978.7M | -15.3x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.02 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -3.5x |
Price/Sales (TTM) | 106.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,670.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
